معرفی
Emily Holmes is a Reader at the Centre for Health Economics and Medicines Evaluation, North Wales Medical School, Bangor University. She is also Chair of the Bangor University Researcher Development & Concordat Group and an Honorary Research Associate at the University of Liverpool's Department of Pharmacology and Therapeutics. Her research focuses on preference elicitation, cost-effectiveness of healthcare interventions, and interdisciplinary global health issues such as antimicrobial resistance (AMR) and active travel advocacy. Key projects include the TRaDe Fellowship (economics of rapid diagnostics for antibiotic reduction) and the NIHR Grace Project (patient-centered radiotherapy consent infrastructure).
Education: PhD in Behavioral Economics & Health Psychology (Bangor University, 2017), MSc Health Economics & Policy (University of Birmingham, 2005), BA Economics (University of Liverpool, 2001).
Research Interests: Discrete choice experiments, patient preferences in healthcare delivery, benefit-risk assessments, and AMR strategies. She leads initiatives like the Wales Active Travel Research Consortium (ATLAS) and supervises students on topics such as dental service preferences and epilepsy treatment priorities.
Awards: Health and Care Research Wales Rising Research Star (2021), multiple poster/presentation awards, and leadership programs (Welsh Crucible, Aurora Leadership).
Grants & Roles: Principal Investigator on active projects (e.g., MOAT 1 for workplace active travel, Health Economics of the Pharmacy Hypertension Service). Active in peer review, university ethics committees, and national initiatives like the NIHR Trial Steering Committees.
Labs/Teams: Co-leads the Grace Project and chairs the Health and Care Research Wales Doctoral Fellowship Awards Panel. Engaged with global health through UN SDG contributions and bilingual public engagement initiatives.
